Arcellx, Inc. (ACLX)
114.73
-0.09
(-0.08%)
USD |
NASDAQ |
Apr 01, 16:00
114.73
0.00 (0.00%)
After-Hours: 19:23
Arcellx Research and Development Expense (TTM) : 157.61M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.71B |
| Bristol Myers Squibb Co. | 9.492B |
| BioMarin Pharmaceutical, Inc. | 700.97M |